Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6W8R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,630
Award facts
- Contract value 100% obligated
- $18,630.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,630.33 to AmerisourceBergen Drug Corp for the supply of KESIMPTA 20 mg/0.4 mL auto-injector pens on January 12, 2026, with completion scheduled for January 13, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to support military healthcare programs globally.
KESIMPTA (ofatumumab) is a monoclonal antibody medication used for the treatment of relapsing forms of multiple sclerosis. This delivery order exemplifies the breadth of specialty pharmaceutical commodities that AmerisourceBergen supplies through its federal contract portfolio, which includes brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains. As a critical pharmaceutical distributor to federal military and healthcare systems, AmerisourceBergen's efficient fulfillment of such orders supports the Defense Health Agency and other government medical institutions in maintaining adequate supplies of essential therapeutic medications.
Quick answers
Who was awarded contract SPE2DR26F6W8R?
SPE2DR26F6W8R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F6W8R worth?
The government has obligated $18,630 on SPE2DR26F6W8R.
Is contract SPE2DR26F6W8R an order under another contract?
Yes. SPE2DR26F6W8R is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6W8R competed?
The extent of competition for SPE2DR26F6W8R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award